Abstract
Host dependency factors (HDFs) required for influenza A virus (IAV) infection represent promising therapeutic targets, as the virus is less likely to develop resistance against host-targeted interventions. However, previous functional genomics studies have yielded inconsistent results. In this study, researchers performed a genome-wide CRISPR/Cas9 screen and developed a novel meta-analysis by information content (MAIC) approach to integrate their findings with existing datasets. The study identified 121 core host factors, including WDR7, CCDC115, and TMEM199, which regulate V-type ATPase assembly and viral entry. Additionally, the human mRNA cap methyltransferase CMTR1 was found to be essential for viral "cap snatching" and immune evasion. Inhibiting CMTR1 significantly enhanced the efficacy of the influenza endonuclease inhibitor Xofluza, suggesting a potent strategy for combination therapy.
Introduction
Influenza remains a significant global health threat due to its rapid mutation rate and the emergence of drug-resistant strains. Targeting host proteins that the virus "hijacks" for replication—host dependency factors—offers a more "evolution-proof" antiviral strategy. Despite numerous previous attempts to map these factors using RNA interference (RNAi), the resulting datasets often lacked reproducibility and overlap. This research addresses this "reproducibility crisis" by providing a definitive, validated list of HDFs using high-resolution CRISPR screening and a new computational framework to reconcile past data.
Methods
The researchers introduced two primary innovations to improve the identification of HDFs:
- Phenotypic Readout via Surface HA: Unlike traditional screens that rely on cell survival, this study used the surface expression of viral Hemagglutinin (HA) as a readout. By using fluorescence-activated cell sorting (FACS) to isolate cells based on HA levels, the team could identify factors involved in every stage of the viral life cycle, from entry to protein export.
- MAIC (Meta-analysis by Information Content): A new algorithm was developed to integrate the CRISPR results with over 30 external datasets, including prior RNAi screens, proteomics, and co-expression data. MAIC weights each source based on its "information content"—its ability to predict known biology and overlap with other high-quality data.
Key Insights and Ideas
The V-type ATPase Assembly Hub
The screen identified WDR7, CCDC115, and TMEM199 as critical factors. While V-type ATPases are known to acidify endosomes for viral entry, these specific proteins are assembly factors. Their loss leads to endo-lysosomal over-acidification, which paradoxically blocks viral entry by trapping or degrading virions before they can release their genome.
CMTR1 and the "Cap Snatching" Vulnerability
IAV lacks the ability to produce its own mRNA caps and must "snatch" them from host mRNAs. The enzyme CMTR1 methylates host mRNA caps; without this modification, the virus cannot effectively steal caps, stalling its replication. Furthermore, the absence of CMTR1 allows the cell's innate immune system (the RIG-I pathway) to better recognize viral RNA, effectively removing the virus's ability to hide from cellular defenses.
Key Results
- 121 Robust Hits: The study established a core set of 121 genes essential for IAV infection, many of which were missed by previous RNAi screens.
- MAIC Superiority: In empirical tests, MAIC consistently outperformed standard meta-analysis tools like Robust Rank Aggregation (RRA) and Vote Counting (VC) in identifying true positives from noisy data.
- Synergy with Xofluza: Knocking out CMTR1 dramatically boosted the effectiveness of the antiviral drug Xofluza (Baloxavir). In CMTR1 knockout cells, a low dose of Xofluza (5 nM) achieved an 85% reduction in infection, compared to only 6% in wild-type cells.
Limitations and Future Work
While the identification of these factors is a major step forward, challenges remain. For instance, WDR7 is a massive protein, making traditional rescue experiments difficult. Additionally, because V-type ATPase assembly factors are essential for general cell health, future research must determine if a therapeutic window exists where these can be safely inhibited to stop viral replication without causing systemic toxicity. The broad-spectrum potential of these targets also warrants further investigation, as they appear necessary for other viruses like Vesicular Stomatitis Virus (VSV).
Summary updated